Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Office and Location: A research opportunity is currently available at the Center for Biologics Evaluation and Research (CBER), in the Office of Therapeutic Products (OTP), under the Office of Cellular
-
unknown PRRSV strains and present a portfolio of biomarkers, cell populations, and/or immune processes to target for revised immunomodulatory design strategies that are catered towards prevention/treatment
-
), Chronic Wasting Disease (CWD), Scrapie, and emerging camel prion diseases. You will receive hands-on training and mentorship while contributing to high-impact studies that combine cell-based systems
-
analyses for methods such as flow cytometry, cell culture/stimulations, and RNA sequencing (bulk, single-cell, spatial) may also be available based on your interests. Research endeavors are intrinsically
-
and researchers engaging in organoid/cell biology research activities including, but not limited to, nutritional physiology, immune system modulation, and gastrointestinal cell culture to support gut
-
opportunities to interpret and communicate research findings. Exposure to additional assays and analyses for methods such as flow cytometry, cell culture/stimulations, and RNA sequencing (bulk, single-cell
-
, immunohistochemistry, cell/tissue processing, and ELISA/immunoblots, and the scientific communication of research findings. Learning Objectives: Under the guidance of a mentor, you will have the opportunity to learn
-
phyllosphere to plants subjected to abiotic stress and/or pathogen infection, (2) understanding the role of host cell wall and carbohydrate composition in microbial community assembly, (3) developing and/or
-
protein expression and purification, biochemical screening assay development, computational structural modeling, cell-based antiviral validation studies, and exposure to preclinical small-animal research
-
virus neutralization assays and/or ELISAs; evaluation of vaccine potency and efficacy in swine and cattle; and use of molecular and cellular techniques such as recombinant DNA technology, DNA sequencing